Functional Chronic Constipation
Conditions
Interventions
Group A: L.reuteri 5drops x 2/day and Placebo of MO x 2/day x 4 weeks
Group B: L.reuteri 5drops x 2/day and MO x 2/day x 4 weeks
Group C:Placebo of L.reuteri 5drops x 2/day and MO x 2/day x 4 wee
Sponsors
Kubota children's clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Person who clears Rome IV criteria At least 2 or more have continued for 1 month or more from the following symptoms Defecation less than twice a week History of excessive stool retention Painful bowel movements Giant fecal lump in the rectum Huge stool history Following establishment of toilet habits the following criteria will also be added At least feces incontinence at least once a week (after defecation in the toilet) A huge chaotic mass that the toilet is clogged 2)The age must be 6 months or more and less than 6 years old 3)Being after the start of weaning food
Exclusion criteria
Exclusion criteria: Exclude those with underlying diseases that can cause constipation. (Hirschsprung disease, Spina bifida, milk allergy etc.) Magnesium oxide preparations exclude diseases that may cause hypermagnesemia (Such as kidney disease) Infants under 6 months, children over 6 years old Infants who have not started baby food
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of defecation | — |
Secondary
| Measure | Time frame |
|---|---|
| Status of defication, pain during defecation, bleeding during defecation, fecal microbiome | — |
Countries
Japan
Contacts
Public ContactMegumi Megumi Kubota
Kubota children's clinic pediatrics
Outcome results
None listed